Autobahn Labs
Palo Alto
About Autobahn Labs
Autobahn Labs is a biotechnology company that accelerates the development of novel therapeutics. It is a collaboration between a Samsara BioCapital-led investor syndicate and Evotec. By combining Samsara's long-term investment philosophy with Evotec’s world-class drug discovery and development capabilities, they believe they can improve patient health by identifying exciting early-stage academic research projects that can spark the development of new therapeutics. It was founded in 2018 and is based in Palo Alto, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Jun 2020)
- Website: autobahn-labs.com
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/autobahn-labs-2238560 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.